Yearly Archives: 2026

MHRA Class 4 Medicines Defect Notification: Levetiracetam Neuraxpharm granules for oral solution in sachet (Neuraxpharm UK Limited) Drug alert number: EL(26)A/40 Date issued: 23 September 2026 Neuraxpharm UK Limited have informed the MHRA that a review of the approved Patient Information Leaflet (PIL) has identified discrepancies between the current Neuraxpharm product safety information and the corresponding [...]

The post MHRA Class 4 Medicines Defect Notification: Levetiracetam Neuraxpharm granules for oral solution in sachet (Neuraxpharm UK Limited) appeared first on Community Pharmacy England.

The Telegraph Dr. James Davies, Director of Research and Insights at Community Pharmacy England, was interviewed by The Telegraph about the UK’s medicines supply chain, including the country’s reliance on overseas manufacturing and the impact of global disruption on medicines availability. Our Director of Research and Insights, Dr. James Davies said: “We rely now more [...]

The post Medicines supply chain and global shortages appeared first on Community Pharmacy England.

27 new products have been added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2026. Community Pharmacy England, on behalf of pharmacy owners, applied to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) for these products to be added to the DND [...]

The post 27 products added to the Discount Not Deducted (DND) list from October 2026 appeared first on Community Pharmacy England.

Pharmacy owners are facing renewed pressure from medicines supply disruption and rising purchase prices, with 248 products granted a price concession for September 2026 and further requests still under consideration by the Department of Health and Social Care (DHSC), meaning the previous record of 257 set in June could be surpassed. The total remains significant [...]

The post Autumn brings renewed pressures on medicines supply appeared first on Community Pharmacy England.

Community Pharmacy England has published its 2025/26 Annual Report, highlighting progress made on behalf of pharmacy owners during another challenging year for the sector. Key outcomes included securing £3.073 billion in CPCF funding for 2025/26, alongside the Government’s agreement to write off £193 million in historic medicines margin over-delivery. Across 2024/25 and 2025/26, we helped [...]

The post Funding, medicines and services: delivering for pharmacy owners in 2025/26 appeared first on Community Pharmacy England.